Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Intel
INTC
|
+$972M |
| 2 |
Cisco
CSCO
|
+$610M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$572M |
| 4 |
International Flavors & Fragrances
IFF
|
+$492M |
| 5 |
Mastercard
MA
|
+$400M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.31B |
| 2 |
DuPont de Nemours
DD
|
+$563M |
| 3 |
Qualcomm
QCOM
|
+$372M |
| 4 |
Merck
MRK
|
+$332M |
| 5 |
Microsoft
MSFT
|
+$305M |
Sector Composition
| 1 | Technology | 23.31% |
| 2 | Consumer Discretionary | 12.99% |
| 3 | Financials | 12.81% |
| 4 | Healthcare | 12.55% |
| 5 | Communication Services | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CVLY
3001
DELISTED
Codorus Valley Bancorp Inc
CVLY
| $639K | ﹤0.01% |
34,745
-1,262
| -4% | -$23.2K |
|
|
CALA
3002
DELISTED
Calithera Biosciences, Inc
CALA
| $639K | ﹤0.01% |
13,200
-311
| -2% | -$15.1K |
|
3003
VolitionRX
VNRX
$67M
| $634K | ﹤0.01% |
167,875
+8,104
| +5% | +$30.6K |
|
|
DZSI
3004
DELISTED
DZS Inc. Common Stock
DZSI
| $634K | ﹤0.01% |
40,765
-1,048
| -3% | -$16.3K |
|
3005
Fennec Pharmaceuticals
FENC
$247M
| $630K | ﹤0.01% |
101,369
-4,680
| -4% | -$29.1K |
|
3006
Mastech Digital
MHH
$89.2M
| $630K | ﹤0.01% |
35,797
-488
| -1% | -$8.59K |
|
|
ABTC
3007
American Bitcoin Corp. Class A Common Stock
ABTC
$6.78B
| $627K | ﹤0.01% |
64
+40
| +167% | +$392K |
|
|
LBC
3008
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $625K | ﹤0.01% |
52,876
-12,870
| -20% | -$152K |
|
3009
First Northwest Bancorp
FNWB
$65.9M
| $624K | ﹤0.01% |
37,583
-1,125
| -3% | -$18.7K |
|
3010
Riverview Bancorp
RVSB
$109M
| $623K | ﹤0.01% |
89,806
-2,563
| -3% | -$17.8K |
|
|
LJPC
3011
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $620K | ﹤0.01% |
146,256
-12,851
| -8% | -$54.5K |
|
3012
Norwood Financial Corp
NWFL
$244M
| $618K | ﹤0.01% |
23,251
-589
| -2% | -$15.7K |
|
3013
Revolve Group
RVLV
$1.72B
| $617K | ﹤0.01% |
13,731
+3,727
| +37% | +$167K |
|
3014
Chemung Financial Corp
CHMG
$256M
| $612K | ﹤0.01% |
14,640
-416
| -3% | -$17.4K |
|
3015
Xeris Biopharma Holdings
XERS
$1.34B
| $612K | ﹤0.01% |
135,618
-12,794
| -9% | -$57.7K |
|
3016
Electromed
ELMD
$209M
| $611K | ﹤0.01% |
57,906
+11,820
| +26% | +$125K |
|
3017
Harrow
HROW
$1.68B
| $608K | ﹤0.01% |
90,102
-4,073
| -4% | -$27.5K |
|
|
SRT
3018
DELISTED
Startek Inc.
SRT
| $601K | ﹤0.01% |
75,650
+340
| +0.5% | +$2.7K |
|
3019
Bankwell Financial Group
BWFG
$363M
| $598K | ﹤0.01% |
22,173
+8,234
| +59% | +$222K |
|
3020
Evolution Petroleum
EPM
$187M
| $597K | ﹤0.01% |
176,732
+50,478
| +40% | +$171K |
|
|
FINV
3021
FinVolution Group
FINV
$2B
| $595K | ﹤0.01% |
84,853
-9,300
| -10% | -$65.2K |
|
|
INBX
3022
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $595K | ﹤0.01% |
29,620
-3,198
| -10% | -$64.2K |
|
3023
Universal Technical Institute
UTI
$1.56B
| $594K | ﹤0.01% |
101,749
-1,494
| -1% | -$8.72K |
|
3024
Information Services Group
III
$268M
| $590K | ﹤0.01% |
134,000
-25,036
| -16% | -$110K |
|
3025
iRadimed
IRMD
$918M
| $590K | ﹤0.01% |
22,887
-639
| -3% | -$16.5K |
|